Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

9.51  +0.55 (+6.14%)

After market: 9.51 0 (0%)

Fundamental Rating

3

Overall BLMN gets a fundamental rating of 3 out of 10. We evaluated BLMN against 134 industry peers in the Hotels, Restaurants & Leisure industry. BLMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLMN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
BLMN had a positive operating cash flow in the past year.
In multiple years BLMN reported negative net income over the last 5 years.
Each year in the past 5 years BLMN had a positive operating cash flow.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -0.06%, BLMN is not doing good in the industry: 63.43% of the companies in the same industry are doing better.
BLMN has a Return On Equity (-0.52%) which is comparable to the rest of the industry.
BLMN's Return On Invested Capital of 5.46% is in line compared to the rest of the industry. BLMN outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLMN is below the industry average of 13.97%.
The last Return On Invested Capital (5.46%) for BLMN is well below the 3 year average (9.55%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROIC 5.46%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN has a worse Operating Margin (4.59%) than 64.93% of its industry peers.
In the last couple of years the Operating Margin of BLMN has grown nicely.
With an excellent Gross Margin value of 71.00%, BLMN belongs to the best of the industry, outperforming 85.82% of the companies in the same industry.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.59%
PM (TTM) N/A
GM 71%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

BLMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BLMN has been reduced compared to 1 year ago.
Compared to 5 years ago, BLMN has less shares outstanding
Compared to 1 year ago, BLMN has a worse debt to assets ratio.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BLMN has an Altman-Z score of 0.94. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
BLMN's Altman-Z score of 0.94 is on the low side compared to the rest of the industry. BLMN is outperformed by 70.15% of its industry peers.
BLMN has a debt to FCF ratio of 35.06. This is a negative value and a sign of low solvency as BLMN would need 35.06 years to pay back of all of its debts.
With a Debt to FCF ratio value of 35.06, BLMN perfoms like the industry average, outperforming 41.79% of the companies in the same industry.
BLMN has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
BLMN has a Debt to Equity ratio of 2.41. This is comparable to the rest of the industry: BLMN outperforms 47.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Altman-Z 0.94
ROIC/WACC0.71
WACC7.65%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.41. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BLMN (0.41) is worse than 80.60% of its industry peers.
A Quick Ratio of 0.33 indicates that BLMN may have some problems paying its short term obligations.
The Quick ratio of BLMN (0.33) is worse than 79.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.33
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -35.74% in the last year.
Measured over the past 5 years, BLMN shows a small growth in Earnings Per Share. The EPS has been growing by 3.30% on average per year.
BLMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.68%.
BLMN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.93% yearly.
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%

3.2 Future

BLMN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.02% yearly.
Based on estimates for the next years, BLMN will show a decrease in Revenue. The Revenue will decrease by -2.92% on average per year.
EPS Next Y-30.46%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
EPS Next 5YN/A
Revenue Next Year-11.5%
Revenue Next 2Y-5.21%
Revenue Next 3Y-2.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 5.63.
98.51% of the companies in the same industry are more expensive than BLMN, based on the Price/Earnings ratio.
BLMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
Based on the Price/Forward Earnings ratio of 7.03, the valuation of BLMN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BLMN is valued cheaply inside the industry as 94.03% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BLMN to the average of the S&P500 Index (22.19), we can say BLMN is valued rather cheaply.
Industry RankSector Rank
PE 5.63
Fwd PE 7.03
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 95.52% of the companies listed in the same industry.
BLMN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BLMN is cheaper than 62.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.9
EV/EBITDA 4.7
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A cheap valuation may be justified as BLMN's earnings are expected to decrease with -5.02% in the coming years.
PEG (NY)N/A
PEG (5Y)1.7
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%

6

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 6.81%, which is a nice return.
Compared to an average industry Dividend Yield of 3.59, BLMN pays a better dividend. On top of this BLMN pays more dividend than 94.78% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.81%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 19.12%!
BLMN has paid a dividend for at least 10 years, which is a reliable track record.
BLMN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3723.47%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (6/20/2025, 8:18:15 PM)

After market: 9.51 0 (0%)

9.51

+0.55 (+6.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners103.97%
Inst Owner Change0.6%
Ins Owners1.65%
Ins Owner Change7.09%
Market Cap808.92M
Analysts54.44
Price Target8.97 (-5.68%)
Short Float %10.43%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 6.81%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-3723.47%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-20 2025-05-20 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.32%
Min EPS beat(2)2.96%
Max EPS beat(2)3.69%
EPS beat(4)3
Avg EPS beat(4)-1.61%
Min EPS beat(4)-13.76%
Max EPS beat(4)3.69%
EPS beat(8)6
Avg EPS beat(8)1.23%
EPS beat(12)10
Avg EPS beat(12)2.7%
EPS beat(16)13
Avg EPS beat(16)4.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-0.32%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)3
Avg Revenue beat(16)-1.56%
PT rev (1m)-10.21%
PT rev (3m)-31.69%
EPS NQ rev (1m)-6.93%
EPS NQ rev (3m)-31.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.82%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 5.63
Fwd PE 7.03
P/S 0.21
P/FCF 30.9
P/OCF 3.55
P/B 2.13
P/tB N/A
EV/EBITDA 4.7
EPS(TTM)1.69
EY17.77%
EPS(NY)1.35
Fwd EY14.23%
FCF(TTM)0.31
FCFY3.24%
OCF(TTM)2.68
OCFY28.16%
SpS44.73
BVpS4.47
TBVpS-3.07
PEG (NY)N/A
PEG (5Y)1.7
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.52%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.58%
ROICexgc 7.54%
OM 4.59%
PM (TTM) N/A
GM 71%
FCFM 0.69%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 35.06
Debt/EBITDA 2.66
Cap/Depr 118.44%
Cap/Sales 5.3%
Interest Coverage 2.88
Cash Conversion 66.07%
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.33
Altman-Z 0.94
F-Score6
WACC7.65%
ROIC/WACC0.71
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.74%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-15.71%
EPS Next Y-30.46%
EPS Next 2Y-13.3%
EPS Next 3Y-5.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.68%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-12.19%
Revenue Next Year-11.5%
Revenue Next 2Y-5.21%
Revenue Next 3Y-2.92%
Revenue Next 5YN/A
EBIT growth 1Y-46.89%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.37%
EBIT Next 3Y11.73%
EBIT Next 5YN/A
FCF growth 1Y-86.19%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-47.45%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%